SPYRIDOULA VASILEIOU to Graft vs Host Disease
This is a "connection" page, showing publications SPYRIDOULA VASILEIOU has written about Graft vs Host Disease.
Connection Strength
0.121
-
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant?in patients with ALL. Blood. 2022 04 28; 139(17):2706-2711.
Score: 0.098
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
Score: 0.023